NASDAQ$VRTX
Vertex Pharmaceuticals Incorporated · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
VRTX Q3 2024 — CAD 2.0M revenue
These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position and results of income for the int. Vertex Pharmaceuticals Incorporated reported Q3 2024 results. Net income of CAD 1K. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: CAD 2.0M.
- Net income: CAD 1K.
- Filed on Form 10-Q (accession 0000875320-24-000223).
Headline financials
Revenue & EPS history
Vertex · Revenue · Quarterly
$2.77B
Revenue by segment
Vertex · $2.27B total across 1 segment · Q3 2023
- TRIKAFTA/KAFTRIO$2.27B+13.1%100.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-0.3%
Avg return
Earnings day
-0.2%
Avg return
5 days after
+1.1%
Avg return
30 days after
46%
32 / 70 earnings
Positive
+6.1%
Q3 2024
Best reaction
-9.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.2% | -0.1% | +3.0% | |
| Q4 2025 | +5.7% | +1.1% | +0.9% | |
| Q3 2025 | -1.1% | -3.9% | +7.4% | |
| Q2 2025 | +2.8% | -0.1% | +5.6% | |
| Q1 2025 | -9.4% | -15.0% | -11.3% | |
| Q4 2024 | -3.1% | -2.3% | +7.0% | |
| Q3 2024 | +6.1% | +9.7% | -1.5% | |
| Q2 2024 | +0.9% | +2.4% | -1.9% | |
| Q1 2024 | +2.3% | +5.4% | +20.4% | |
| Q4 2023 | -2.0% | -0.4% | -3.0% | |
| Q3 2023 | +0.5% | -0.7% | -6.0% | |
| Q2 2023 | -2.4% | -1.6% | -2.2% | |
| Q1 2023 | +1.6% | +2.2% | -5.0% | |
| Q4 2022 | -3.8% | -2.5% | -5.9% | |
| Q3 2022 | +0.9% | +1.0% | +0.6% | |
| Q2 2022 | +4.7% | +8.7% | +2.2% | |
| Q1 2022 | -7.2% | -12.3% | -1.6% | |
| Q4 2021 | +0.5% | +7.0% | +1.4% | |
| Q3 2021 | +2.0% | +4.0% | +10.3% | |
| Q2 2021 | -0.3% | -1.1% | -1.1% | |
| Q1 2021 | +2.2% | +0.6% | -2.3% | |
| Q4 2020 | -5.1% | -6.0% | -9.0% | |
| Q3 2020 | +0.0% | +1.3% | +8.8% | |
| Q2 2020 | -2.4% | -1.1% | -3.1% | |
| Q1 2020 | -2.2% | +3.0% | +12.1% | |
| Q4 2019 | -2.3% | +3.1% | -3.6% | |
| Q3 2019 | -1.2% | +0.8% | +12.1% | |
| Q2 2019 | +5.8% | +3.6% | +6.2% | |
| Q1 2019 | +0.0% | +0.8% | -1.3% | |
| Q4 2018 | -3.0% | -3.5% | -5.0% | |
| Q3 2018 | -4.9% | -2.2% | -7.9% | |
| Q2 2018 | +0.6% | -0.3% | +1.1% | |
| Q1 2018 | +0.6% | -1.7% | +1.5% | |
| Q4 2017 | +3.9% | -6.8% | +2.1% | |
| Q3 2017 | -4.9% | -1.0% | -3.0% | |
| Q2 2017 | -3.6% | -6.3% | -5.4% | |
| Q1 2017 | +1.7% | +1.8% | +3.1% | |
| Q4 2016 | +3.8% | +2.6% | +4.7% | |
| Q3 2016 | -0.0% | -1.5% | +10.9% | |
| Q2 2016 | +1.3% | +3.4% | +2.2% | |
| Q1 2016 | +3.1% | — | — | |
| Q4 2015 | +0.6% | — | — | |
| Q3 2015 | +4.3% | — | — | |
| Q2 2015 | +5.6% | — | — | |
| Q1 2015 | -1.7% | — | — | |
| Q4 2014 | -7.7% | — | — | |
| Q3 2014 | -1.5% | — | — | |
| Q2 2014 | -3.7% | — | — | |
| Q1 2014 | -2.0% | — | — | |
| Q4 2013 | +3.6% | — | — | |
| Q3 2013 | -7.8% | — | — | |
| Q2 2013 | +1.5% | — | — | |
| Q1 2013 | -1.9% | — | — | |
| Q4 2012 | -2.8% | — | — | |
| Q3 2012 | -6.8% | — | — | |
| Q2 2008 | -1.6% | — | — | |
| Q1 2012 | +2.5% | — | — | |
| Q4 2011 | +2.3% | — | — | |
| Q3 2011 | -0.7% | — | — | |
| Q2 2011 | +4.5% | — | — | |
| Q1 2011 | -1.8% | — | — | |
| Q4 2008 | -1.2% | — | — | |
| Q4 2010 | -1.2% | — | — | |
| Q3 2009 | -0.1% | — | — | |
| Q3 2010 | -0.1% | — | — | |
| Q2 2010 | +5.1% | — | — | |
| Q2 2009 | +5.1% | — | — | |
| Q1 2010 | -0.8% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q4 2009 | -0.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro